Attachment 1 - Purchase Description.pdf
PDF 163 KB Posted
- Solicitation number
- 75N95025Q00042
About this file
This document is a Purchase Description related to a federal contract opportunity announced in a Sources Sought notice.
The purpose of this acquisition is to provide sequencing kits and accessories to the Center for Alzheimer's Disease and Related Dementias for use in long-read sequencing on Oxford Nanopore systems to support the Global Parkinson's Genetics Program (GP2). The required items include PromethION flow cells, ligation sequencing kits, flow cell wash kits, and sequencing auxiliary vials. The anticipated period of performance consists of a base period with two 12-month option periods from 9/30/2025 to 9/30/2027.
The government is conducting market research to determine the availability and capability of qualified sources, including small businesses, to meet these requirements. Interested parties are requested to submit capability statements addressing the technical, administrative, and business qualifications to the Contracting Officer by November 27, 2024. The government may issue a solicitation after reviewing the responses, but responses to this notice will not be considered adequate responses to a future solicitation.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment 1
PURCHASE DESCRIPTION
1. Statement of Need and Purpose: The purpose of this acquisition is to provide supplies to the Center for Alzheimer’s Disease and Related Dementias for neurodegenerative disease research for the purpose of long read sequencing on Oxford Nanopore manufactured sequencing systems. These reagents will be used to identify causative genes for neurodegenerative diseases.
2. Background Information and Objective: The Global Parkinson’s Genetics Program (GP2) is an ambitious program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.
3. Generic Name of Product: Sequencing kits
4. Purchase Description: The following brand name or equal supplies are required:
Description Catalog No.
Delivery Date Estimated Delivery Date
9/30/2025 9/30/2026 9/30/2027
Quantity Optional
QTY1
Optional
QTY2
PromethION Flow Cells, v10.4.1 FLO-PRO114M 25 25 25
Ligation Sequencing Kit XL V14 SQK-LSK114-XL 4 4 4
Flow Cell Wash Kit XL EXP-WSH004-XL 9 9 9
Sequencing Auxiliary Vials V14 EXP-AUX003 34 34 34
5. Salient characteristics:
The flow cell must be able to generate up to 290 Gb for sequencing DNA, cDNA or native RNA in real-time.
The flow cell must be compatible with Nanopore PromethION 48 sequencers in form, fit, and function
The flow cell must contain Application-Specific Integrated Circuit (ASIC) to control and measure sequencing process
The flow cell must contain recyclable electrical components.
6. Additional Requirements: All deliverables required under this contract shall be
Attachment 1 packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and Contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
7. Period of Performance: The anticipated period of performance for this requirement consists of a base period with two 12-month option periods as follows:
Base Period Delivery Date: 9/30/2025 Option Period 1 Delivery Date: 9/30/2026 Option Period 2 Delivery Date: 9/30/2027
File details come from the government source that posted it. Updated .